Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Shares withheld for taxes Chief Medical Officer gave up 10,250 shares (to pay taxes)
  2. 4 Shares withheld for taxes General Counsel, Secretary gave up 6,952 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 10,250 shares (to pay taxes)
  4. 4 Shares withheld for taxes CTO & SVP of CMC gave up 10,700 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 2,464 shares (to pay taxes)
  6. 4 Grant or award Director acquired 34,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 11,883 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 2,389 shares (to pay taxes)
  10. 4 Shares withheld for taxes General Counsel, Secretary gave up 4,944 shares (to pay taxes)
  11. 4 Shares withheld for taxes CTO & SVP of CMC gave up 7,609 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 11,883 shares (to pay taxes)
  13. 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Chief Financial Officer bought 11,766 shares
  16. 4 Open-market buy Director bought 11,766 shares
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Director acquired 17,000 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 102,000 shares (grant or award)
  20. 4 Grant or award Director acquired 17,000 shares (grant or award)

Page 3 of 13 · 246 filings